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A B S T R A C T
In the past, the practice of symptom validity assessment (SVA) in European countries was considerably 
lagging behind developments in North America, with the topic of malingering being largely taboo for 
psychological and medical professionals. This was being changed in the course of the past decade with a 
growing interest in methods for the assessment of negative response bias. European estimates of 
suboptimal test performance in civil and social forensic contexts point at base rates similar to those 
obtained in North America. Symptom over-reporting and underperformance in neuropsychological 
examinations appear to occur in a sizable proportion of patients. Although there is considerable progress in 
establishing SVA as an integral and indispensable part of psychological and neuropsychological assessment 
in some countries, others appear to lag behind. In some countries there is still enormous resistance against 
SVA from part of the neuropsychological and psychiatric communities.
© 2013 Colegio Oficial de Psicólogos de Madrid. All rights reserved. 
Evaluación de la validez de los síntomas en Europa: evolución y situación actual
R E S U M E N
Hasta no hace mucho tiempo la evaluación de la validez de los síntomas en Europa, tanto en su vertiente 
científico-académica como en la práctica profesional, estaba muy por detrás de los avances que se produ-
cían en Norteamérica y particularmente la simulación se consideraba un tema tabú entre los profesionales 
de la Psicología y la Medicina. En la última década las cosas parecen haber cambiado, observándose un in-
cremento en el interés por la evaluación del sesgo de respuesta negativo. Las tasas base de prevalencia ob-
tenidas utilizando pruebas de rendimiento subóptimo en contextos civiles y forenses son similares a las 
obtenidas en Norteamérica. Los fenómenos de exageración de síntomas en autoinformes y rendimiento in-
suficiente en pruebas neuropsicológicas parecen ocurrir en semejante proporción de pacientes. Aunque se 
han producido avances notables en el establecimiento de la evaluación de la validez de los síntomas como 
una parte integral e indispensable de la evaluación psicológica y neuropsicológica en algunos países euro-
peos, en otros sin embargo la situación es mucho más incipiente. De hecho, en algunos países sigue exis-
tiendo una gran resistencia a la evaluación de la validez de los síntomas proveniente de algunos profesiona-
les de la psiquiatría y la neuropsicología.
© 2013 Colegio Oficial de Psicólogos de Madrid. Todos los derechos reservados.
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Symptom Validity Assessment
In the past 20 years, symptom validity assessment (SVA) has 
become a leading topic in clinical neuropsychology, with few areas 
surpassing it in terms of the interest and controversy that it has 
attracted as well as the proliferation of published research papers. 
Neuropsychological assessment has always maintained a close link 
to standardized testing, which makes clinical neuropsychology a 
data driven discipline and, at the same time, presents the greatest 
challenge to the validity of individual diagnostic decision making. 
Neuropsychological test results are highly dependent upon the 
willingness of the patient to employ optimal test effort, and 
neuropsychologists are usually not capable of determining the 
validity of test data on the basis of clinical intuition (e.g., Heaton, 
Smith, Lehman, & Vogt, 1978). 
The era of modern SVA began in the late 1980s, when standardized 
forced-choice symptom validity tests (SVTs) were introduced in the 
context of a renewed interest in malingering research. In the 
following 25 years, neuropsychologists have maintained a leading 
role in the development of methods and in conceptual refinement in 
what may be described as the differential diagnosis of non-authentic 
symptom production and symptom report (e.g., Carone & Bush, 
2013; Sweet & Guidotti-Breting, 2013).
In line with Greve, Bianchini, and Brewer (2013), the term SVT is 
used in the context of this paper as a superordinate term for all 
methods that tap negative response bias both in symptom production 
(including underperformance in psychological tests) and symptom 
over-reporting. For cognitive SVTs determining possible 
underperformance, Larrabee (2012) has recently proposed the term 
performance validity tests (PVTs), while those SVTs determining the 
validity of self reported mental or cognitive impairment may be 
called self-report validity tests (cf. Figure 1).
The present paper focusses primarily on the current state of PVT 
usage, the traditional field of SVA, while self-report measures of 
symptom validity will not be discussed in detail. The tradition of 
self-report validity scales is far more complex and has had a long 
tradition in personality research, clinical psychology, and various 
branches of applied psychology. 
Methods to determine the validity of symptom presentation 
and symptom report
Standarized psychological
instruments:
Symptom validity test = SVTs
Other methods
Performance
validity test
= PVTs
Self-report
validity test
= SRVTs
Determinations
about possible
underperformance
Determinations
about possible
over-reporting
Analysis of consistency / 
plausibility between and 
withhin data sources, incl.
tCFIBWJPSBMPCTFSWBUJPOT
tNPUPSCFIBWJPS
tBDUJWJUJFTPGEBJMZMJGF
tSFMJBCMFUIJSEQBSUZ
   information
tFMFDUSPQIZTJPMPHZ
tNPOJUPSJOHPGNFEJDBUJPO
Determinations about possible negative response bias:
Credibility of symptom report
Validity of test profile
Cooperativeness in neuropsychological examination
Figure 1. System of methods to determine symptom validity.
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Short historical survey of symptom validity assessment in Europe
The problem of malingering, in terms of its definition and 
detection, has deep historical roots, which shall not be traced here in 
detail. In the 1811 edition of the Classical Dictionary of Vulgar 
Tongue, first published in 1785, a keyword “King’s Bad Bargain” 
defines as one of those bad bargains “a malingeror, or soldier, who 
shirks his duty” (Grose, 1811). For civil society, the 19th century 
history of the railway spine (Erichsen, 1867; Thomann & Rauschmann, 
2003) has fully demonstrated the difficult conceptualization of 
bizarre symptom presentations in the context of liability claims. 
Attempts at medical theory building trying to conform to patient 
behavior may, from today’s perspective, appear no less bizarre than 
the symptomatology they aimed to explain. Yet, unsolved questions 
as to a valid differential diagnosis of intentional vs. unintentional 
symptom distortions continue to haunt the medical and psychological 
literature (cf. Merten & Merckelbach, 2013b).
The Franco-Swiss psychologist André Rey (1941, 1958) pioneered 
a field which we conceptualize today as SVA. He introduced a 
number of instruments aiming to detect invalid test performance, 
such as the Fifteen-Item Test (FIT), the Dot Counting Test (DCT) or the 
Word Recognition Test (WRT). While these tests perform poorly in 
contrast to modern PVTs (e.g., Hartman, 2002), Rey (1958) took a 
rather modern stance in that he warned not to base far reaching 
diagnostic decisions solely on the results of a single test, but to 
include multiple information such as the individual constellation of 
the case, personality, and motivation (cf. Frederick, 2002, for a sound 
historical appraisal of Rey’s contribution to SVA). There were other 
approaches to tackle the problem of malingering detection which, in 
modern terminology, would be called embedded measures (that 
means applying empirically derived cut scores or indices based on 
standard test results to serve as an indicator of symptom validity). 
For example, before leaving Germany for British Columbia, Otfried 
Spreen worked on measures to identify feigned cognitive impairment 
within the Visual Retention Test (Benton, 1945; Benton & Spreen, 
1961). Incidentally, Spreen (1963) was also the author of the first 
German MMPI version. Gudjonsson and Shackleton (1986) later 
generated another embedded indicator of response validity from the 
Standard Progressive Matrices.
Forced-choice PVTs were developed in the United States in the 
1960s. This methodological approach, which allows for determinations 
of intentional response manipulations in cases of below-chance 
performance (Merten & Merckelbach, 2013a, for a recent review), 
prepared the transition into the modern era of SVA. There was an 
early European attempt to develop a forced-choice approach for the 
detection of invalid performance in Benton’s (1945) Visual Retention 
Test. However, this work by Loewer and Ulrich (1971) has largely 
remained unnoticed, probably because it was published in German 
language. Thus, it is a paper by Pankratz (1983) that is usually 
conceived to mark the introduction of forced-choice testing in the 
field of examining possible malingering in cases of claimed memory 
impairment. Although he also authored an article in German language 
(Pankratz & Paar, 1988) there was no detectable repercussion on 
assessment practice in the German speaking countries.
SVA began to be used and discussed on a broader basis by American 
neuropsychologists in the early 1990s. During this time they 
developed a wealth of publications and a range of standardized, 
commercially available tests, whilst the whole of Europe appeared to 
be lagging behind. The developmental delay can be estimated to 
amount to approximately a decade for the most advanced countries 
(in terms of SVA); in other countries, the delay appears to be much 
longer still. Yet, a number of PVTs were developed in Europe in the 
1990s, such as the Coin-in-the-Hand Test (Kapur, 1994), the 
Amsterdam Short-Term Memory Test (Schmand, de Sterke, & 
Lindeboom, 1999), and the Bremen Symptom Validation (Heubrock & 
Petermann, 2000). A number of PVTs were adapted to European 
languages, with a multilingual computerized version of the Word 
Memory Test (WMT, Green, 2003) being the most prominent of them.
Also in the 1990s, some reviews (e.g., Heubrock & Petermann, 
1998) and the first empirical studies were published (e.g., Schmand 
et al., 1998) marking the beginning of a broader research interest in 
symptom validity assessment. In North America, the term malingering 
research was used in the beginning, and symptom validity assessment 
primarily centred on the determination of possible malingering. In 
this vein, several instruments have this term in their names, like the 
German-language Aggravations und Simulationstest, AST 
(Exaggeration and Malingering Test, Eberl & Wilhelm, 2007). It was 
only after the turn of the millennium that a conceptual clarification 
took place on a larger scale. Today, as Merten and Merckelbach 
(2013b, p. 122) summarized, most experts in SVA would agree that 
“a) SVTs may help to clarify the nature of certain symptom 
constellations; b) symptom validity assessment comprises both self-
report measures that tap over-endorsement of symptoms and tasks 
(i.e., ‘effort tests’) that tap cognitive underperformance (Larrabee, 
2012, referred to these cognitive SVTs as performance validity test); 
c) symptom over-endorsement and/or cognitive underperformance 
represent two aspects of negative response bias: in some cases they 
occur together, in other cases only one of the two aspects is present 
[…]; d) malingering is considered to be only one possible source of 
negative response bias.”
It was only with the beginning of the third millennium that 
European SVT research was performed on a larger scale and symptom 
validity assessment began to be introduced on a larger scale into 
practical work of neuropsychologists. First workshops were organized 
in some countries (as in Britain or The Netherlands), raising immense 
interest. In London, a post-qualification training day on symptom 
validity, organized by the British Psychological Society Division of 
Neuropsychology in February 2006, attracted sizable audience. One 
of the speakers, Dr. Brooks, “described the meeting as a turning point 
in British neuropsychological practice” (Alcott, 2006, p. 1).
A landmark was reached with the First European Symposium on 
Symptom Validity Assessment, held in Würzburg, Germany, in 2009, 
followed by updates in London, UK, in 2011 (Anderson, 2010; 
Plohmann, 2011) where major SVT researchers presented. Finally, the 
third symposium, held in Wuerzburg again, in 2013, fully focussed 
on European developments and perspectives (Plohmann, in this 
issue). The fourth symposium is planned for Maastricht, The 
Netherlands, in two years’ time from now.
The bulk of published European research on SVA is authored by 
researchers from only four countries: Germany, Great Britain, The 
Netherlands, and Spain. Only few published studies are authored 
from psychologists of other nationalities, such as Austria (e.g., 
Schiemann, 2003), Portugal (Martins & Martins, 2010; Simões et al., 
2010), or Switzerland (Giger, Merten, Merckelbach, & Oswald, 2010) 
while there is no or almost no evidence for substantial research 
activities in some major European nations like France or Italy. This 
might reflect large differences in the degree of acceptance that 
symptom validity assessment has reached within Europe.
In the following paragraphs, we will describe the reasons why 
valid determinations about the genuineness of personal injury and 
mental health claims are increasingly important and call for reliable 
methods to distinguish between legitimate and illegitimate claims. 
Furthermore, the results of a recent survey among neuropsychologists 
are reported, and summaries of the developments in four European 
countries will be given. 
Claims culture: The British example
In many European countries, public compensation schemes, 
social security, and social welfare systems have come to the limits of 
their capacity, and some branches of the private insurance industry 
are aching under the burden of personal injury claims and the cost 
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of mental health care, with an ever increasing number of minor 
mental disorders to result in long-term sick leave and retreat from 
work. Although the public appears to be well aware of abuse and 
fraudulent claims and scores of spectacular fraud cases have been 
published (e.g., Frei, 2004; as an example see the incredible reports 
from Zakynthos, the Greek “Island of the Blind”, Squires, 2013), 
nobody knows the true financial burden of false symptom report and 
false imputations. For the United States, Chafetz and Underhill (in 
press) have recently estimated the cost of malingering in selected 
Social Security programs. For adult mental disorder claimants, the 
authors estimated the annual cost at about $20 billion. The acuity of 
the problem shall be illustrated in some more detail by the situation 
in the United Kingdom.
In recent years, the UK claims culture has become more 
widespread, increasing the need for performance validity testing. 
This is reflected in the “disability paradox” showing an increase in 
disability claims (rise from just under 2.5 million to 3.2 million) 
whilst the average health status improves (Department of Work & 
Pensions, 2013). The 2012 statistics of this UK Department show that 
there were 3.28 million recipients of Disability Living Allowance 
(DLA) and £1.2 billion of total benefit expenditure is overpaid due to 
fraud. However, this is likely to be only the tip of the iceberg, as the 
validity of claims is not routinely screened using standardized tests. 
Factors which may contribute to malingering or symptom 
exaggeration include the “benefits trap”, which refers to disincentives 
for returning to work being built into the UK welfare system (i.e., 
often people with disabilities cannot earn as much as their benefits 
if they return to work), although reforms to increase work incentives 
are only just starting to be made to this system.
The growing claims culture is also evident in the litigation system. 
There was a five per cent increase in the proportion of accidents 
involving third-party injury claims in England and Wales last year, 
making Britain more litigious than America and placing it as the 
“Whiplash capital or the world” (Ministry of Justice, 2013). 
Government figures show that between 2006 and 2011 the number 
of reported road traffic accidents fell by 20%. Over the same period, 
there was a 60% rise in road traffic accident personal injury claims. 
According to industry figures, the level of undetected fraud is 
currently considered to cost the industry around £1 billion a year 
and they claim that of every hour of every day 15 fraudulent 
insurance claims are exposed in the UK (Association of British 
Insurers, 2012; Ministry of Justice, 2013). Press coverage suggests 
that this is due to a “claims manufacturing industry” that has “gone 
into overdrive” to entice drivers into making easy claims which has 
in turn increased the prevalence rate of fraud (Massey, 2013). 
Prior to the increase in claims culture, the prevalence rate of 
performance invalidity (measured by failure on the Test of Memory 
Malingering) in UK head injury litigants referred for 
neuropsychological assessment was found to be 33% (Moss, Fokias, 
Jones, & Quinn, 2003). This is fairly consistent with the estimates of 
malingering and symptom Exaggeration in North America 
(Mittenberg, Paton, Canyock, & Condit, 2002). As disability benefits 
and the “benefits trap” may increase the risk of symptom exaggeration 
and malingering, there is also a clear need to investigate how 
common this is currently with non-litigating NHS disability cohorts 
as well as more up to date prevalence rates for groups perusing 
litigation. 
Despite this growing risk of symptom exaggeration and 
malingering, in the UK there is a problem with using PVTs to diagnose 
malingering as the unmasking of malingering is seen as a task for the 
legal process rather than the medical one (Halligan, Bass, & Oakley, 
2004). Malingering is therefore seen as a taboo subject and most UK 
clinicians are skeptical about whether PVTs can differentiate 
“malingering” from other forms of symptom invalidity (e.g., 
somatoform disorders and iatrogenic symptoms; McMillan et al., 
2009). This is contrary to the North American diagnostic criteria for 
malingering that infer intent from the combined improbability of 
events (i.e., multiple failures on symptom validity indicators; 
Larrabee, Greiffenstein, Greve, & Bianchini, 2007). 
Surveys on Symptom Validity Assessment in Europe
A first survey on symptom validity practice in Europe was 
performed in Great Britain by McCarter, Walton, Brooks, and Powell 
(2009). It has shown that only 16% of clinicians working solely in 
clinical settings employ PVTs for more than half of their assessments, 
compared to 73% of those conducting medico-legal assessments, but 
only 59% of respondents in the survey admitted to always or almost 
always formally evaluating performance validity with litigants using 
PVTs. The PVTs most commonly used by UK clinicians were the Test 
of Memory Malingering (TOMM, Tombaugh, 1996) (50% of all 
respondents), the Rey 15-Item Test (Rey, 1958) (24% of all 
respondents), and the WMT (Green, 2003) (24% of all respondents). 
Only 5% of respondents used embedded symptom validity indicators 
and only 11% of clinicians used self-report SVTs such as the MMPI 
(McCarter et al., 2009). The UK therefore seems to be behind the 
North American recommendations for symptom validity assessment, 
which stipulates that multiple sources of information should be used 
to detect response bias (Heilbronner et al., 2009), and this is 
necessary for the neuropsychological criteria for malingering (e.g., 
Bianchini, Greve, & Glynn, 2005; Slick, Sherman, & Iverson, 1999).
A second survey was performed in six European countries: 
Denmark, Finland, Germany, Italy, The Netherlands, and Norway 
(Dandachi-FitzGerald, Ponds, & Merten, in press). In this survey the 
median estimate of insufficient effort was 10% in clinical and 15% in 
forensic assessments. The median estimate of malingering (i.e., 
insufficient effort specifically due to malingering) was 4% in clinical 
and 10% in forensic assessments. And while at least the forensic 
estimates of insufficient effort and malingering were substantially 
lower than empirical studies show, these numbers still illustrate an 
increased awareness in neuropsychologists in these European 
countries as opposed to few decades ago, when the general view 
prevailed that these phenomena were virtually non-existent. 
Interestingly, the survey revealed substantially lower prevalence 
estimates of malingering in own clinical and forensic assessments 
than in general (Figure 2). Neuropsychologists appear to be hesitant 
to acknowledge the occurrence of malingering in their own patients. 
Perhaps neuropsychologists are still too much inclined to believe 
what a patient says and does during an assessment. This stresses the 
importance of using objective methods for evaluating symptom 
validity. 
So, what are the tools and tests neuropsychologists use to evaluate 
the validity of the obtained diagnostic data? The five methods most 
frequently indicated for the determination of symptom validity were 
(in rank order): discrepancies between records, self-reporting, and 
observed behaviour; severity of cognitive impairment inconsistent 
with the condition; pattern of cognitive impairment inconsistent 
with the condition; implausible self-reported symptoms in the 
interview; and implausible changes in test scores across repeated 
examinations. All objective empirically validated methods (e.g., 
stand-alone PVTs, embedded indicators, validity scales on objective 
personality tests) ranked at the bottom. Looking at the analyses per 
society, there were two exceptions: the Dutch respondents (stand-
alone PVTs ranked second) and the Norwegian respondents (stand-
alone PVTs ranked fifth). 
The most commonly used PVTs were: the ASTM, Rey FIT, TOMM, 
and the WMT.
As might be expected, only a small minority of respondents (12%) 
indicated always using a PVT in a clinical assessment. Surprisingly, it 
was also a minority of the respondents that stated they always 
included a PVT in a forensic assessment (45%). In this respect, the 
survey showed that considerable differences existed between the 
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respondents of the various societies, with lowest numbers in Italy 
(22%) and Finland (14%) and highest numbers in the Netherlands (70%) 
and Norway (69%) (Figure 3). This supports the notion that important 
cultural differences still exist in how neuropsychologists in the various 
European countries relate to the topic of symptom validity. 
In conclusion, on the positive side there is acknowledgement that 
non-credible symptom reports and malingering occur. The surveys’ 
findings, however, also show that the use of clinical impressions still 
prevails over the use of empirically validated tests to determine the 
symptom credibility. Although these subjective methods certainly 
have their value, it is vital that they are being used in conjunction 
with empirically validated tests. 
Spain
In the last few decades, several research teams and lines have 
been established in Spain regarding research on malingering and 
SVA in different domains such as the neuropsychological context 
(e.g., Vilar-López, Gómez-Río, Caracuel-Romero, Llamas-Elvira, & 
Pérez-García, 2008), the forensic context (e.g., Arce, Fariña, Carballal, 
& Novo, 2009; Jiménez-Gómez & Sánchez-Crespo, 2004; Sánchez-
Crespo, Jiménez-Gómez, Ampudia-Rueda, & Merino-Barragán, 2012; 
Zaldivar-Basurto, García-Montes, López-Rios, Molina-Moreno, & 
Santiago, 2007), the medico-legal context (e.g., Capilla-Ramírez & 
González-Ordi, 2009; González-Ordi, Capilla-Ramírez, Santamaría, 
& Casado-Morales, 2012), González-Ordi, Santamaría, & Fernández-
Marín, 2010; the military context (e.g., García-Silgo & Robles-
Sánchez, 2010), and more generally the study of verbal and non-
verbal cues to detect deception (e.g., Masip, Garrido, & Herrero, 
2009).
Within these fields of research, empirical results are slowly 
becoming more and more available for the professionals by means of 
the publication of journal monograph issues (Lemos-Giráldez, 2005), 
book chapters devoted to malingering and SVA (González-Ordi & 
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Figure 2. Prevalence estimates of malingering: own versus general estimates in clinical and forensic assessments(median percentages). Interquartile ranges were 19, 5, 30, and 
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Gancedo-Rojí, 1999; Vilar-López & Aliaga, 2009), or theoretical and 
practical handbooks (e.g., González-Ordi, Santamaría, & Capilla-
Ramírez, 2012), as well as continuing postgraduate education 
through workshops, symposia and conferences, generally in medico-
legal and forensic contexts.
Spanish adaptations of the internationally most widespread tests 
used for the assessment of symptom validity and malingering have 
fostered scientific, forensic, and medico-legal applications among 
psychological and neuropsychological practitioners. Remarkably, a 
significant number of Spanish-adapted symptom validity 
assessments rapidly became available to clinical and forensic 
professionals within less than half a decade (e.g., the Spanish 
adaptation of the Structured Inventory of Malingered Symptomatology 
– SIMS, González-Ordi & Santamaria, 2009; the Minnesota 
Multiphasic Personality Inventory-2-Restructured Form – MMPI-2-
RFl, Santamaría, 2009; the Personality Assessment Inventory – PAI, 
Ortiz-Tallo, Santamaría, Cardenal, & Sánchez, 2011; and the Test of 
Memory Malingering – TOMM, Vilar-López, Pérez-García, & Puente, 
2011). Moreover, specific forensic protocols were developed (e.g., 
Arce & Fariña, 2005). 
However, in spite of this promising research panorama there are 
numerous shadows regarding the professional practice of SVA and 
malingering assessment. Firstly, there is no reliable data available of 
applied assessment SVA protocols in different contexts. Furthermore, 
SVA and the question of possible malingering are not yet regularly 
taken into account in many forensic and medico-legal contexts. A 
guide for good practice is still in demand. A general professional 
debate and discussion have not yet occurred in Spain, as is the case 
in other European countries, like Germany and Switzerland. Secondly, 
a risky application of SVTs (like the SIMS) can be identified. This is 
the case when instruments are used in isolation and without an 
adequate conceptual and methodological knowledge on the part of 
the test user who may see a “magic road” to the detection of 
deception in these tests. In face of this, the role of modern SVA in 
detection of malingering and the importance of a multidimensional 
approach in different contexts has to be popularized among 
professionals (Capilla & Gonzalez-Ordi, 2009; Merten & Merckelbach, 
2013b). Multidimensional and multi-method approaches may 
contribute to avoid inaccurate diagnoses and to decrease the rate of 
false positive and false negative classification errors, both having a 
considerable economic and psychosocial impact.
In summary, although there are quality seeds available to get a 
good harvest in Spain, further research and educational effort will be 
necessary for establishing sound practice guidelines and protocols, 
both for researchers and professionals. They should aim to (1) extend 
a regular use of SVA to any context where negative response biases 
can occur (clinical, forensic, and medico-legal); (2) adapt SVA to 
specific disorders (like pain disorder, anxiety and affective disorders, 
amnesia, posttraumatic stress, sequelae of sexual assault and abuse, 
etc.); (3) promote a multidimensional approach to SVA and avoid 
simplified diagnostic decision making based on the isolated use of 
instruments; and (4) carefully avoid the classification errors (false 
positives and false negatives).
The Netherlands
In 1997, a Dutch textbook on clinical neuropsychology was 
published that nicely illustrated the skepticism and controversies on 
the topic of malingering, which dominated at that time in the 
Netherlands. This textbook already contained a chapter on 
malingering, in which the authors advised their colleagues to always 
administer a symptom validity test when a patient has an incentive to 
demonstrate cognitive deficits (Schmand & Ponds, 1997). In the same 
book, the authors of a chapter on the chronic whiplash syndrome 
stated: “In our opinion, the hypothesis that the desire for financial 
gain would play a role in whiplash needs not to be taken seriously” 
(Van Zomeren & Saan, 1997). In those early days, it was believed that 
malingering was only a problem in the United States and not in 
Europe, due to the American claim culture with huge financial stakes 
(e.g., Ponds, de Lugt, Verhey, & Jolles, 1995). Neuropsychologists were 
reluctant to introduce SVTs, because they felt it as a sign of mistrust 
towards the patient, opposing their primary task of determining the 
veracity of the complaints. The use of SVTs implies misinforming the 
patient, which was considered to conflict with the ethical code of 
psychologists. As formulated by a prominent colleague: “Psychologists 
should not allow themselves to be hired to play detective for the 
insurance companies” (Hofstee, 2005). 
From the nineties, SVA has nevertheless been an active research 
topic in the Netherlands. In 1999, the Amsterdam Short-Term 
Memory Test, a Dutch PVT was published (Schmand et al., 1999), and 
English and German versions became available (Schmand & 
Lindeboom, 2005). The WMT (Green, 2003), MSVT (Green, 2004), 
and the SIMS (Merckelbach & Smith, 2003) have been made available 
in Dutch. As in Northern America, the initial focus was on the 
detection of malingering in forensic assessments with SVTs, in those 
days often referred to as “malinger tests”. However, SVTs were soon 
applied in clinical settings. Van der Werf, Prins, Jongen, van der Meer, 
and Bleijenberg (2000) noted that a modest proportion of patients 
with chronic fatigue syndrome showed non-credible performance. 
In 2005, a Dutch-Spanish study was published, in which the WMT 
was used in a clinical sample of schizophrenic patients (Gorissen, 
Sanz, & Schmand, 2005). Lower scores on the WMT were associated 
with higher levels of negative symptoms and it was hypothesized 
that an underlying motivational deficit could explain the WMT 
failure rate in this sample. These studies are exemplary of the 
transitional period towards a better understanding of what SVTs 
actually measure (i.e., the behaviors of cognitive underperformance 
and symptom over-reporting and not directly the underlying motive), 
a period marked by great conceptual confusion. The nomenclature 
expanded and terms such as “suboptimal effort”, “cognitive 
underperformance”, and “symptom exaggeration” were being used 
interchangeably, even as synonyms of the concept of malingering. 
The conceptual confusion surrounding SVA has certainly 
hampered resolving the controversies among Dutch 
neuropsychologists. The initially assumed dichotomy between true 
patients and malingerers and the lack of conceptual clarity probably 
evoked a counter reaction. In recent years, many Dutch 
neuropsychologists have stressed that cognitive underperformance 
and symptom exaggeration are not necessarily conscious behaviors 
nor behaviors motivated by external gains. Instead, emphasis is 
placed on explanations such as pain, fatigue, and emotional factors 
(e.g., the ill-defined concept of ‘cry for help’, struggle for recognition) 
for symptom invalidity. Currently, the majority of Dutch 
neuropsychologists acknowledge cognitive underperformance and 
symptom over-reporting as threats to the validity of the test results 
and most of them, at least in forensic assessments, use SVTs. However, 
the idea that symptom invalidity can arise from deceitful behavior of 
the examinee still seems to be a taboo. 
Recent research activities have focused on symptom validity in 
patients clinically referred for neuropsychological assessments. In a 
mixed psychiatric sample, 8% of the patients failed two SVTs, the 
SIMS and ASTM (Dandachi-FitzGerald, Ponds, Peters, & Merckelbach, 
2011). The WMT has also been researched in memory clinic patients. 
Failing the effort indices of the WMT negatively impacted the 
association between hippocampal damage and memory performance 
(Rienstra, Groot et al., 2013), thereby obscuring normal brain-
behavior relationships. Analysis of the profile of WMT subtests 
contributed to the prediction of conversion to dementia within 2 
years (Rienstra, Twennaar, & Schmand, 2013). Thus, SVTs may even 
be used to aid the early diagnostics of dementia. 
Also, there have been experimental studies into the residual 
effects of feigning. Volunteers instructed to first malinger 
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psychological symptoms and then to give up their role and act 
honestly continued to show heightened symptom levels on re-
administration of a symptom list as compared to participants being 
asked to fill out the list twice in an honest manner. Cognitive 
dissonance is hypothesized as the underlying mechanism. These 
studies give a first indication of how malingering may evolve in 
somatoform presentations (Merckelbach, Dandachi-FitzGerald, van 
Mulken, Ponds, & Niesten, in press; Merckelbach, Jelicic, & Pieters, 
2011).
Great Britain
In Great Britain (GB), the widespread use of PVTs has not quite 
caught on in clinical practice (McCarter et al., 2009) and many 
clinicians remain skeptical about their necessity. Despite this lack of 
popularity, their importance is recognized by the British Psychological 
Society (BPS), who has written a position paper on performance 
validity testing, which recommends their use in clinical and medico-
legal practice (McMillan et al., 2009). 
The majority of British PVT research has focused on test validation 
but there is a paucity of research, showing that GB’s need and interest 
in PVTs is not reflected in the evidence base. This lack of research is 
recognized by the BPS, who highlights the need for more British PVT 
research (MacMillan et al., 2009). The Coin-in-the-Hand Test (CIHT, 
Kapur, 1994), a bedside PVT, is the only PVT which has been 
developed in GB and is utilized by clinicians (McCarter et al., 2009). 
Although the Warrington Recognition Memory Test (RMT, 
Warrington, 1984) was developed in GB and is used as a test of 
response bias (Millis, 1994) it was not originally developed as a PVT 
and there is no British validation data. The CIHT uses chance levels 
cutoffs and has been shown to have good sensitivity with simulator 
groups and good specificity with severe cognitive impairment 
(Hanley, Baker, & Ledson, 1999; Kapur, 1994; Kelly, Baker, Broek, 
Jackson, & Humphries, 2005; Schroeder, Peck, Buddin, Heinrichs, & 
Baade, 2012). This worse than chance performance methodology was 
applied in the very early development of PVTs (Pankratz, 1983), but 
since this time methodology has become much more sophisticated, 
given its likely limited sensitivity with “known groups” of clinical 
malingerers. Nevertheless, the CIHT remains a useful bedside screen.
Although the TOMM and WMT were reported as the most 
commonly used PVTs in GB, there is only one British validation study 
for the WMT (Hall, Worthington, & Venables, 2013) and no validation 
studies for the TOMM. The tests which have been the most extensively 
validated in GB are the Coin-in-the-Hand Test, the Rey 15 item test 
(Fisher & Rose, 2005; Kelly et al., 2006), and the Medical Symptom 
Validity Test (Gill, Green, Flaro, & Pucci, 2007; Singhal, Green, Ashaye, 
Shankar, & Gill, 2009), although there are still few validation studies 
with regards to these tests. The continued popularity of the Rey is 
surprising, as it has been shown to lack sensitivity to malingering 
and simulation whilst also lacking specificity (Larrabee, 2005; 
Vallabhajosula & van Gorp, 2001). The remaining British PVT 
validation studies have tended to be with stand-alone measures 
which are rarely used (e.g., Autobiographical Memory Test, Jenkins, 
Kapur, & Kopelman, 2009) or embedded PVTs which again have little 
popularity (e.g., Multiple Errands Test, Castiel, Alderman, Jenkins, 
Knight, & Burgess, 2012; Wechsler Memory Scale-Third Edition, 
Mental Control Test, Kelly et al, 2006; Wechsler Memory Scale, Word 
List Recognition, Hacker & Jones, 2008). The British studies have 
generally been in relation to non-litigant neurological groups, such 
as traumatic brain injury (Wogar, van den Broek, Bradshaw, & 
Szabadi, 1998) and dementia (Singhal et al., 2009) and one study 
applying PVTs to medically unexplained symptoms (Kemp et al., 
2008). The lack of litigant studies (with the exception of Moss et al., 
2003) is surprising given that this is the area which is most applicable 
to PVTs, given the high prevalence rate of symptom exaggeration in 
litigant groups. There is also a lack of British PVT studies with chronic 
pain or in the context of criminal forensic neuropsychological 
assessments and this is also reflected in clinical practice with few 
neuropsychologists providing these specialist assessments. 
Interestingly, all of the British studies have used simulation validation 
paradigms and there are no British known-groups studies with 
clinical malingerers. This trend to use simulation paradigms is 
behind the North American literature, which has shifted from 
simulation designs to known-groups studies, the latter often 
regarded to be a more sophisticated approach. The lack of known-
groups studies may stem partly from the lack of acceptance that 
“known group” designs actually reflect “malingerers”.
Overall, there is clearly a substantial need for PVTs in GB with the 
growing claims culture but this is not reflected in the sophistication 
of the application of PVTs or the British research evidence base. 
Germany
At the turn of the millennium, available German-language 
publications with the keyword malingering were a rarity and the 
topic of malingering was largely taboo, but an early review article 
(Heubrock & Petermann, 1995) apparently preceded later 
developments. Although two German-language tests (Eberl & 
Wilhelm, 2007; Heubrock & Petermann, 2000) were published and 
embedded measures were proposed by Schmidt-Atzert and 
colleagues (e.g., Schmidt-Atzert, Bühner, Rischen, & Warkentin, 
2004) for the d2 Test of Attention, one of the most widespread 
German-language performance tests, controversy among 
(neuro)psychologists prevailed. German neuropsychologists were 
primarily identified with a clinical and therapeutic relationship to 
their patients and were little acquainted with the strictly impartial 
role a forensic expert has to assume. Still, in 2003, a prominent 
German neuropsychologist pronounced, in the context of assessing 
possible malingering, in a public neuropsychological newsgroup: “I 
am not inclined to witness and stand by –when neuropsychology 
moves back into military psychology.” The therapeutic role to which 
psychologists are usually trained is implicitly linked with an attitude 
to believe what patients tell them. In the context of the ongoing 
debate about SVA, this is reflected by a statement of Noeker and 
Petermann (2011), who maintained that low scores on PVTs may 
erroneously suggest malingering in patients with functional and 
somatoform syndromes. Even if such patients produced an excessive 
array of symptoms, they nevertheless responded “in a subjectively 
truthful manner” (p. 450), and the inconsistency between different 
data should be understood by the expert as “the sensitive expression 
of major subjective distress and impairment” (p. 450).
Most empirical research focused on German language adaptations 
of PVTs (like the Amsterdam Short-Term Memory Test, the Medical 
Symptom Validity Test, and the Word Memory Test) as well as on the 
examination of embedded measures. A series of articles examining 
base rate estimates of negative response bias in forensic populations 
found numbers comparable to those known from North America 
(e.g., Stevens, Friedel, Mehren, & Merten, 2008). In accordance with 
more recent estimates from the United States, the prevalence of 
negative response bias approaches or exceeds the 50 % mark in some 
claimant populations (Merten, Thies, Schneider, & Stevens, 2009). 
Some research work found a larger interest among the scientific 
community, such as the first study to test a stand-alone symptom 
validity test in individuals with mental retardation (Brockhaus & 
Merten, 2004) and a study discussing and examining the limits of 
effort testing (Merten, Bossink, & Schmand, 2007), a topic which is 
very prominent in current developments. In the context of distorted 
self-report in the clinic (psychosomatic rehabilitation), a recent 
study by Göbber, Petermann, Piezga, and Kobelt (2012) found 
elevated scores on the Structured Inventory of Malingered 
Symptomatology (SIMS, Widows & Smith, 2005) in 33 % of German 
respondents and 50 % of respondents with migration background.
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In the course of the last five or six years, SVA has increasingly 
been adapted by referral sources, including courts and state agencies, 
so much so that this is exerting pressure on hesitant or sceptical 
(neuro)psychologists and neurologists/psychiatrists to examine the 
genuineness of symptom report and the validity of test profiles with 
modern methods. Similarly to what is known from North America in 
the 1990s, referral agencies stipulate and stimulate the progress in 
the field. Today we have a somewhat paradoxical situation in 
Germany: PVT usage in medico-legal contexts appears to be fully 
accepted by neurologists, but the neuropsychological community 
continues to be divided. Many neuropsychologists are still hesitant 
to integrate modern approaches to SVA even into their forensic work. 
In psychiatry, there is an even deeper division. On the one hand, a 
growing number of psychiatrists appear to appreciate working 
closely with psychologists and include SVA results to make 
determinations about the genuineness of symptom report and the 
validity of profiles (e.g., Stevens, Fabra, & Merten, 2009). On the other 
hand, a group of influential German psychiatrists undertook to 
question the appropriateness of SVA in the context of forensic 
examinations in patients with mental disorders (e.g., Dressing, 
Foerster, Widder, Schneider, & Falkai, 2011). For a discussion of this 
deeply rooted controversy which has a profound impact on forensic 
psychiatric practice at the present time, see Schmidt, Lanquillon, and 
Ullmann (2011) and Merten and Merckelbach (2013b); an analysis of 
potential pitfalls for opponents of SVA was presented by Green and 
Merten (2013).
Remarkably, some sceptics or opponents to SVA appear to adopt 
the published English-language literature in a distorted way. To give 
a most striking example, the term malingering is wrongly understood 
as referring exclusively to symptom invention (or “pure” malingering), 
while other aspects of malingering are neglected. Thus, base rate 
estimates for malingered symptomatology are questioned on the 
basis of a wrong conceptualization (e.g., Dressing et al., 2011). 
However, a number of professional guidelines appear to be more 
circumspect, more open to include modern methods of SVA, and do 
not restrict psychiatric determinations to clinical decision making 
(e.g., Deutsche Rentenversicherung, 2012).
State of the art, recent developments, and outlook
While the European continent covers less than 7 % of the Earth’s 
land area, it is quite diverse in terms of political and linguistic 
structure and comprises about 50 independent states with several 
dozens of official languages spoken by their native populations. 
Within the continent, neuropsychology certainly finds itself in 
diverse stages of development, and the role of forensic 
neuropsychology in the legal systems is probably as diverse 
(moreover, the states partly adhere to the inquisitorial, partly to the 
adversarial system, with different roles of the forensic expert within 
the legal system).
A similar diversity can be found in documented SVA practice and 
research activities as has been outlined above. In some countries, 
major developments have occurred to a degree that the gap between 
American and local SVA practice appears to have been narrowed 
while there is no documented proof of systematic SVA usage from 
most European countries. The recent statement of Sweet and 
Guidotti-Breting (2013) that there is no more controversy surrounding 
SVTs but “… this is merely a pseudo-controversy in that the number 
of neuropsychologists who hold this viewpoint now represent a very 
small minority” (p. 15) is certainly not true for Europe. A closer 
analysis of an ongoing harsh controversy in Switzerland and Germany 
was presented by Plohmann (2013) at the recent Third European 
Symposium on SVA.
Yet, professional guidelines for forensic assessment appear to 
include increasingly firm statements about SVT usage. However, as 
far as can be seen, Great Britain is the only country so far in which a 
special professional guideline dealing with SVA has been passed 
(McMillan et al., 2009).
Adoption of SVA in the majority of European countries is 
hampered by the diversity of national languages within the continent. 
While the development of original tests (like the ASTM in The 
Netherlands and TBFN and AST in Germany) is the exception, the 
bulk of SVA will have to rely on adaptions of international instruments 
(in particular of North American origin) as is the practice in 
neuropsychological assessment altogether. However, even 
adaptations of foreign language tests require proper validation. 
Moreover, the majority of practically working neuropsychologists in 
some major nations (like Germany, France, and Spain) are not used 
to resort to English language resources in their daily routines. To 
facilitate access to current developments, publications in their 
national languages appear to be mandatory (e.g., González-Ordi, 
Santamaría et al., 2012; Merten & Dettenborn, 2009). However, in a 
number of other countries (like The Netherlands and the Scandinavian 
nations), command of English language is a basic requirement for 
professionals.
Apart from the three major European symposia on Symptom 
Validity Assessment, a number of other events have marked the last 
few years. Workshops and national conference symposia on SVA 
were held in Austria, Germany, Great Britain, Switzerland, The 
Netherlands, and possibly in some more countries. In 2012, a 
workshop on the assessment of malingering and related response 
styles was held by Dr. Richard Rogers in Basel, Switzerland. Symposia 
on SVA were held at the World Congress of the International Brain 
Injury Association (IBIA), Edinburgh 2012, at two congresses of the 
International Academy of Law and Mental Health (IALMH), Berlin 
2011 and Amsterdam 2013, at the annual meetings of the European 
Association of Psychology and Law (EAPL), Maastricht 2008, 
Gothenburg 2010, and Nicosia 2012, and at the joint meeting of the 
Federation of European Societies of Neuropsychology (ENS), 
Amsterdam 2010 and Berlin 2013.
With regard to SVA in Europe, it may be said that we have come a 
long way, but there is an even longer way before us. Whenever 
neuropsychologists enter the legal arena as independent experts, 
they have to deal with an elevated rate of invalid test profiles in 
claimants. SVA will help them to make valid determinations about 
possible response bias and to answer the legal questions with more 
confidence and more convincingly than if they rely on their clinical 
intuition. As a consequence, an appropriate and responsible use of 
these methods can –and will– enhance the competence and the 
esteem of neuropsychologists in the legal arena. In clinical and 
rehabilitation contexts SVA can play a significant role in differential 
diagnosis and help clarifying the nature of certain symptom 
constellations as well as factors contributing to the course of reported 
symptoms. In these contexts, however, the way to go is even longer.
Conflicts of interest
Dr. Merten, Prof. Schmand, Prof. González-Ordi, and Santamaría 
have participated in the adaptations of numerous validity tests to 
German, Dutch and Spanish respectively. Prof. Schmand is the author 
of the Amsterdam Short-Term Memory Test. No conflicts of interest 
were declared by the other authors.
References
Alcott, D. (2006). Post-qualification training day on symptom validity testing attracts 
capacity audience. Newsletter, The British Psychological Society Division of Neuropsy-
chology, 5, 1-2.
Anderson, S. (2010). Conference report: The First European Symposium on Symptom 
Validity Assessment (May 8 – 9 2009). Zeitschrift für Neuropsychologie, 21, 65.
Arce, R., Fariña, F., Carballal, A., & Novo, M. (2009). Creación y validación de un proto-
colo de evaluación forense de las secuelas psicológicas de la violencia de género 
[Development and validation of a protocol for forensic evaluation of psychological 
sequelae of sexual violence]. Psicothema. 21, 241–247.
 T. Merten et al. / Clínica y Salud 24 (2013) 129-138 137
Arce, R., & Fariña, F. (2005). Peritación psicológica de la credibilidad del testimonio, la 
huella psíquica y la simulación: El sistema de evaluación global (SEG) [Psychologi-
cal expert opinion on the credibility of witness accounts, on psychological injury 
and malingering: The Global Evaluation System, GES]. Papeles del Psicólogo, 26, 
59–77.
Association of British Insurers (2012). No hiding place insurance fraud exposed. Retrie-
ved from https://www.abi.org.uk/~/media/Files/Documents/Publications/Public/
Migrated/Fraud/ABI%20no%20hiding%20place%20-%20insurance%20fraud%20ex-
posed.ashx
Benton, A. L. (1945). A visual retention test for clinical use. Archives of Neurology and 
Psychiatry, 64, 212-216.
Benton, A. L., & Spreen, O. (1961). Zur Simulation intellektueller Leistungsdefekte im 
Benton-Test [About malingered deficits of intelligence performance in the Visual 
Retention Test]. Psychologische Beiträge, 7, 147-150.
Bianchini, K. J., Greve, K. W., & Glynn, G. (2005). On the diagnosis of malingered pain-
related disability: Lessons from cognitive malingering research. The Spine Journal, 5, 
404-417.
Brockhaus, R., & Merten, T. (2004). Neuropsychologische Diagnostik sub opti malen 
Leistungsverhaltens mit dem Word Memory Test [Neuropsychological assessment 
of suboptimal performance: The Word Memory Test]. Nervenarzt, 75, 882-887.
Capilla-Ramírez, P., & González-Ordi, H. (2009). Protocolo para la detección de la simu-
lación del dolor en la práctica clínica: estudio de casos [Clinical protocol for the 
detection of malingered pain: Case studies]. Trauma, 20, 255–263.
Carone, D. A., & Bush, S. S. (2013). Introduction: Historical perspectives on mild trau-
matic brain injury, symptom validity assessment, and malingering. In D. A. Carone 
& S. S. Bush. (Eds.), Mild traumatic brain injury: Symptom validity assessment and 
malingering (pp. 1-29). New York: Springer.
Castiel, M., Alderman, N., Jenkins, K., Knight, C., & Burgess, P. (2012). Use of the Multi-
ple Errands Test–Simplified Version in the assessment of suboptimal effort. Neu-
ropsychological Rehabilitation, 22, 734-751.
Chafetz, M., & Underhill, J. (in press). Estimated costs of malingered disability. Archives 
of Clinical Neuropsychology.
Dandachi-FitzGerald, B., Ponds, R., & Merten, T. (in press). Symptom validity and neu-
ropsychological assessment: A survey of practices and beliefs in six European coun-
tries. Archives of Clinical Neuropsychology. doi:10.1093/arclin/act073 
Dandachi-FitzGerald, B., Ponds, R. W. H. M., Peters, M. J. V., & Merckelbach, H. (2011). 
Cognitive underperformance and symptom over-reporting in a mixed psychiatric 
sample. The Clinical Neuropsychologist, 25, 812-828.
Department for Work & Pensions (2013). Simplifying the welfare system and making 
sure work pays. London: The Stationary Office.
Deutsche Rentenversicherung (2012). Leitlinien zur sozialmedizinischen Beurteilung. 
Sozialmedizinische Beurteilung bei psychischen und Verhaltensstörungen [Professional 
guidelines of the German Pension Fund for independent medical examinations: 
Mental and behavioral disorders]. Berlin: Author.
Dressing, H., Foerster, K., Widder, B., Schneider, F., & Falkai, P. (2011). Zur Anwendung 
von Beschwerdenvalidierungstests in der psychiatrischen Begutachtung [On the 
application of symptom validity tests in psychiatric forensic examination]. Nerve-
narzt, 82, 388-390.
Eberl, A., & Wilhelm, H. (2007). Aggravations- und Simulationstest AST 4.0 [Exaggera-
tion and Malingering Test] (2nd edition). Essen: Mnemo-Verlag. 
Erichsen, J. E. (1867). On railway and other injuries of the nervous system. Philadelphia, 
PA: Henry C. Lea.
Fisher, H. L., & Rose, D. (2005). Comparison of the effectiveness of two versions of the 
Rey memory test in discriminating between actual and simulated memory impair-
ment, with and without the addition of a standard memory test. Journal of Clinical 
and Experimental Neuropsychology, 27, 840-858.
Frederick, R. I. (2002). A review of Rey’s strategies for detecting malingered neurops-
ychological impairment. Journal of Forensic Neuropsychology, 2, 1-25.
Frei, M. (2004, July 29). Wie sich Simulanten verraten [How malingerers reveal them-
selves]. Tages-Anzeiger, p. 26.
García-Silgo, M., & Robles-Sánchez, J. I. (2010). Estudio de las bajas temporales para el 
servicio por motivos psicológicos: mejoras en la detección de psicopatología y si-
mulación de trastorno mental en las Fuerzas Armadas [Malingering in psychologi-
cal sick leaves in the military]. Sanidad Militar: Revista de Sanidad de las Fuerzas 
Armadas de España, 66, 154–162.
Giger, P., Merten, T., Merckelbach, H., & Oswald, M. (2010). Detection of feigned crime-
related amnesia: A multi-method approach. Journal of Forensic Psychology Practice, 
10, 140-163.
Gill, D., Green, P., Flaro, L., & Pucci, T. (2007). The role of effort testing in independent 
medical examinations. Medico-Legal Journal, 75, 64-71.
Göbber, J., Petermann, F., Piegza, M., & Kobelt, A. (2012). Beschwerdenvalidierung bei 
Rehabilitanden mit Migrationshintergrund in der Psychosomatik [Symptom valida-
tion in patients with migration background in psychosomatic medicine]. Rehabili-
tation, 51, 356-364.
González-Ordi, H., & Gancedo-Rojí, M. (1999). Evaluación de la simulación de respues-
ta: diagnóstico, técnicas y procedimientos [Malingering: Assessment, techniques, 
and procedures]. In A. Ruano, J. M. Muñoz-Céspedes, & C. Cid-Rojo (Coords.), Psico-
logía de la Rehabilitación (pp. 405-441). Madrid: Fundación MAPFRE-Medicina.
González-Ordi, H., Santamaría, P., & Fernández-Marín, P. (2010). Precisión predictiva 
del Inventario Estructurado de Simulación de Síntomas – SIMS en el contexto mé-
dicolegal [Predictive accuracy of the Structured Inventory of Malingered Sympto-
matology—SIMS in the medicolegal setting]. Edupsykhé, 9, 3-22.
González-Ordi, H., Capilla-Ramírez, P., Santamaría, P., & Casado-Morales, M. I. (2012). 
Abordaje multidisciplinar para la detección de la simulación en lumbalgia crónica. 
[A multidisciplinary approach to the detection of malingering in chronic lower back 
pain]. Trauma Fundación MAPFRE, 23, 145–154.
González-Ordi, H., & Santamaría, P. (2009). Adaptación española del Inventario Estruc-
turado de Simulación de Síntomas [Spanish adaptation of the Structured Inventory 
of Malingered Symptomatology]. Madrid: TEA Ediciones.
González-Ordi, H., Santamaría, P., & Capilla-Ramírez, P. (Eds.). (2012). Estrategias de 
detección de la simulación: Un manual clínico multidisciplinar [Malingering detection 
strategies : A multidisciplinary clinical manual]. Madrid : TEA Ediciones. 
Gorissen, M., Sanz, J. C., & Schmand, B. (2005). Effort and cognition in schizophrenia 
patients. Schizophrenia Research, 78, 199-208.
Green, P. (2003). Green’s Word Memory Test: User’s manual. Edmonton, Canada: Green’s 
Publishing.
Green, P. (2004). Green’s Medical Symptom Validity Test (MSVT) for Microsoft Windows: 
User’s Manual. Edmonton, Canada: Green’s Publishing.
Green, P., & Merten, T. (2013). Noncredible explanations of noncredible performance 
on symptom validity tests. In D. A. Carone & S. S. Bush. (Eds.), Mild traumatic brain 
injury: Symptom validity assessment and malingering (pp. 73-100). New York: Sprin-
ger.
Greve, K. W., Bianchini, K. J., & Brewer, S. T. (2013). The assessment of performance and 
self-report validity in persons claiming pain-related disability. The Clinical Neurop-
sychologist, 27, 108–137.
Grose, F. (1811). Dictionary of the vulgar tongue. A Dictionary of buckish slang, university 
wit, and pickpocket eloquence. Retrieved from http://www.freeinfosociety.com/me-
dia/pdf/3934.pdf
Gudjonsson, G. H., & Shackleton, H. (1986). The pattern of scores on Raven’s Matrices 
during ‘faking bad’ and ‘non-faking’ performance. British Journal of Clinical Psycho-
logy, 25, 35-41.
Hacker, V. L., & Jones, C. (2009). Detecting feigned impairment with the word list re-
cognition of the Wechsler Memory Scale. Brain Injury, 23, 243-249.
Hall, V. L., Worthington, A. & Venables, K. (in press). A UK pilot study: The specificity 
of the Word Memory Test effort sub-tests in acute minimal to mild head injury. 
Journal of Neuropsychology.
Halligan, P. W., Bass, C., & Oakley, D. A. (Eds.) (2003). Malingering and illness deception. 
Oxford: Oxford University Press.
Hanley, J. R., Baker, G. A., & Ledson, S. (1999). Detecting the faking of amnesia: A com-
parison of the effectiveness of three different techniques for distinguishing simula-
tors from patients with amnesia. Journal of Clinical and Experimental Neuropsycho-
logy, 21, 59-69.
Hartman, D. E. (2002). The unexamined lie is a lie worth fibbing. Neuropsychological 
malin gering and the Word Memory Test. Archives of Clinical Neuropsychology, 17, 
709-714.
Heaton, R. K., Smith, H. H., Lehman, R. A. W., & Vogt, A. T. (1978). Prospects for faking 
believable deficits on neuropsychological testing. Journal of Consulting and Clinical 
Psychology, 46, 892-900.
Heilbronner, R. L., Sweet, J. J., Morgan, J. E., Larrabee, G. J., Millis, S. R., & Conference 
Participants (2009). American Academy of Clinical Neuropsychology consensus 
conference statement on the neuropsychological assessment of effort, response 
bias, and malingering. The Clinical Neuropsychologist, 23, 1093-1129.
Heubrock, D. (1995). Neuropsychologische Diagnostik bei Simulationsverdacht - ein 
Überblick über Forschungsergebnisse und Untersuchungsmethoden [Neuropsy-
chological assessment of suspected malingering: Research results and evaluation 
techniques]. Diagnostica, 41, 303-321.
Heubrock, D., & Petermann, F. (1998). Neuropsychological assessment of suspected 
malingering: Research results, evaluation techniques, and further directions of re-
search and application. European Journal of Psychological Assessment, 14, 211-225.
Heubrock, D., & Petermann, F. (2000). Testbatterie zur Forensischen Neuropsychologie, 
TBFN. Testmanual. Neuropsychologische Diagnostik bei Simulationsverdacht [Forensic 
Neuropsychological Test Battery. Manual]. Frankfurt: Swets Test Services.
Hofstee, W. K. B. (2005). De psycholoog als detective? Kanttekeningen bij malingering- 
en integriteitstests [The psychologist as a detective? Comments on malingering and 
integrity tests]. De Psycholoog, 40, 670-674.
Jenkins, K. G., Kapur, N., & Kopelman, M. D. (2009). Retrograde amnesia and malinge-
ring. Current Opinion in Neurology, 22, 601-605.
Jiménez-Gómez, F., & Sánchez-Crespo, G. (2004). La falsificación de las técnicas psico-
métricas: un estudio con el MMPI-2 [The falsification of psychometric techniques: A 
study with the MMPI-2]. Salamanca: Universidad de Salamanca.
Kapur, N. (1994). The Coin-in-the-Hand Test: A new “bedside” test for the detection of 
malingering in patients with suspected memory disorder. Journal of Neurology, 
Neurosurgery and Psychiatry, 57, 385-386.
Kelly, P. J., Baker, G. A., Broek, M. D., Jackson, H., & Humphries, G. (2005). The detection 
of malingering in memory performance: The sensitivity and specificity of four 
measures in a UK population. British Journal of Clinical Psychology, 44, 333-341.
Kemp, S., Coughlan, A. K., Rowbottom, C., Wilkinson, K., Teggart, V., & Baker, G. (2008). 
The base rate of effort test failure in patients with medically unexplained symp-
toms. Journal of Psychosomatic Research, 65, 319-325.
Larrabee, G. J. (2005). Assessment of malingering. In G. J. Larrabee (Ed.), Forensic neu-
ropsychology: A scientific approach (pp. 115–158). New York: Oxford University Press.
Larrabee, G. J. (2012). Performance validity and symptom validity in neuropsychologi-
cal assessment. Journal of the International Neuropsychological Society, 18, 625-631.
Larrabee, G. J., Greiffenstein, M. F., Greve, K. W., & Bianchini, K. J. (2007). Refining diag-
nostic criteria for malingering. In G. J. Larrabee (Ed.), Assessment of malingered neu-
ropsychological deficits (pp. 334-371). New York: Oxford University Press.
Lemos-Giráldez, S. (2005). Simulación, engaño y mentira [Malingering, deception and 
lies]. Papeles del Psicólogo, 26, 57–58.
Loewer, H. D., & Ulrich, K. (1971). Eine Alternativ-Wahl-Form des Benton-Testes zur 
besseren Erfassung von Aggravation und Simulation [A forced-choice version of the 
Visual Retention Test for improved assessment of malingering]. In E. Duhm (Hrsg.), 
Praxis der klinischen Psychologie, Band 2 (pp. 63-75). Göttingen: Hogrefe.
138 T. Merten et al. / Clínica y Salud 24 (2013) 129-138
Martins, M., & Martins, I. P. (2010). Memory malingering: Evaluating WMT criteria. 
Applied Neuropsychology, 17, 177-182.
Massey, R. (2013, May 27). Half of whiplash claims are bogus: Faked injuries driving a 
£1billion-a-year racket. The Daily Mail. Retrieved from http://www.dailymail.co.uk/
news/article-2331858/Half-whiplash-claims-bogus-Faked-injuries-driving-1bi-
llion-year-racket.html
Masip, J., Garrido, E., & Herrero, C. (2009). Heuristic versus systematic processing of 
information in detecting deception: Questioning the truth bias. Psychological Re-
ports, 105, 11–36.
McCarter, R. J., Walton, N. H., Brooks, D. N., & Powell, G. E. (2009). Effort testing in 
contemporary UK neuropsychological practice. The Clinical Neuropsychologist, 23, 
1050-1066.
McMillan, T. M., Anderson, S., Baker, G., Berger, M., Powell, G. E., & Knight, R. (2009) 
Assessment of effort in clinical testing of cognitive functioning for adults. Leicester, 
UK: British Psychological Society.
Merckelbach, H., Dandachi-FitzGerald, B., Van Mulken, P., Ponds, R., & Niesten, I. (in 
press). Exaggerating psychopathology produces residual effects that are resistant to 
corrective feedback: An experimental demonstration. Applied Neuropsychology: Adult. 
Merckelbach, H., Jelicic, M., Pieters, M. (2011). The residual effect of feigning: how 
initial feigning may evolve into a less conscious form of symptom reporting. Journal 
of Clinical and Experimental Neuropsychology, 33, 131-139.
Merckelbach, H., & Smith, G. P. (2003). Diagnostic accuracy of the Structured Inventory 
of Malingered Symptomatology (SIMS) in detecting malingering. Archives of Clinical 
Neuropsychology, 18, 145-152.
Merten, T., Bossink, L., & Schmand, B. (2007). On the limits of effort testing: Symptom 
validity tests and severity of neurocognitive symptoms in nonlitigant patients. Jo-
urnal of Clinical and Experimental Neuro psycho logy, 29, 308-318.
Merten, T., & Dettenborn, H. (Eds.) (2009). Diagnostik der Beschwerdenvalidität [Symp-
tom validity assessment]. Berlin: Deutscher Psychologen Verlag.
Merten, T., & Merckelbach, H. (2013a). Forced-choice tests as experiments in the diffe-
rential diagnosis of intentional symptom distortion. Journal of Experimental Psycho-
pathology, 4, 20-37.
Merten, T., & Merckelbach, H. (2013b). Symptom validity testing in somatoform and 
dissociative disorders: A critical review. Psychological Injury and Law, 6, 122-137.
Merten, T., Thies, E., Schneider, K., & Stevens, A. (2009). Symptom validity testing in 
claimants with alleged posttraumatic stress disorder: Com paring the Morel Emo-
tional Numbing Test, the Structured Inventory of Malingered Symptomatology, and 
the Word Memory Test. Psychological Injury and the Law, 2, 284-293.
Millis, S. R. (1994). Assessment of motivation and memory with the Recognition Me-
mory Test after financially compensable mild head injury. Journal of Clinical Psycho-
logy, 50, 601-605.
Ministry of Justice (2013). Written Evidence from the Misistry of Justice (WL 55). Retrie-
ved from http://www.publications.parliament.uk/pa/cm201314/cmselect/cmtran/
writev/whiplash/wl55-56.pdf
Mittenberg, W., Patton, C., Canyock, E. M., & Condit, D. C. (2002). Base Rates of Malin-
gering and Symptom Exaggeration. Journal of Clinical and Experimental Neuropsy-
chology, 24, 1094-1102.
Moss, A., Jones, C., Fokias, D., & Quinn, D. A. (2003) The mediating effects of effort upon 
the relationship between head injury severity and cognitive functioning. Brain In-
jury, 17, 377-387.
Noeker, M., & Petermann, F. (2011). Simulation neurologischer versus psychischer Bes-
chwerden. Notwendigkeit unterschiedlicher Validierungsstrategien [Malingering 
of neurological vs. mental complaints: Necessity of different validation strategies]. 
Psychotherapeut, 56, 449-454.
Ortiz-Tallo, M., Santamaría, P., Cardenal, V., & Sánchez, P. (2011). Adaptación española 
del PAI [Spanish adaptation of the PAI]. Madrid: TEA Ediciones.
Pankratz, L. (1983). A new technique for the assessment and modification of feigned 
memory deficit. Perceptual and Motor Skills, 57, 367-372
Pankratz, L., & Paar, G. (1988). Test zur Symptomvalidität zur Einschätzung funktione-
ller Symptome [A symptom validity test for the evaluation of functional symp-
toms]. Zeitschrift für Klinische Psychologie, Psychopathologie und Psychotherapie, 36, 
130-137.
Plohmann, A. M. (2011). Zweite Europäisches Symposium zur Diagnostik der Beschwer-
denvalidität. Tagungsbericht [Second European Symposium on Symptom Validity 
Assessment: Conference report]. Zeitschrift für Neuropsychologie, 22, 303-305.
Plohmann, A. (2013, June). Common arguments against SV assessment: The psychiatry 
debate in Germany and Switzerland. Paper presented at the Third European Sympo-
sium on Symptom Validity Assessment. Würzburg, Germany.
Plohmann, A., & Merten, T. (2013). The third European Symposium on Symptom Vali-
dity Assessment. Facts and controversies. Clínica y Salud, 25, 197-203.
Ponds, R., de Lugt, M., Verhey, F., & Jolles, J. (1995). Malingering bij neuropsychologisch 
onderzoek [Malingering in neuropsychological assessment]. De Psycholoog, 30, 357-361.
Rey, A. (1941). L’examen psychologique dans les cas d’encéphalopathie traumatique 
[The psychological examination in cases of traumatic encephalopathy]. Archives de 
Psychologie, 28, 286-340.
Rey, A. (1958). L’examen clinique en psychologie [The clinical examination in psycholo-
gy]. Paris: Presses Universitaires de France.
Rienstra, A., Groot, P. F. C., Spaan, P. E. J., Majoie, C. B. L. M., Nederveen, A. J., Walstra, 
G. J. M., … Schmand, B. (2013). Symptom validity testing in memory clinics: hippo-
campal-memory associations and relevance for diagnosing mild cognitive impair-
ment. Journal of Clinical and Experimental Neuropsychology, 35, 59-70.
Rienstra, A., Klein Twennaar, M., & Schmand, B. (2013). Neuropsychological characte-
rization of patients with the WMT dementia profile. Archives of Clinical Neuropsy-
chology, 28, 463-475.
Sánchez-Crespo, G., Jiménez-Gómez, F., Ampudia-Rueda, A., & Merino-Barragán, V. 
(2012). In search of a fast screening method for detecting the malingering of cogni-
tive impairment. European Journal of Psychology Applied to Legal Context, 4, 135–158.
Santamaría, P. (2009). Adaptación española del MMPI-2-RF [Spanish adaptation of the 
MMPI-2-RF]. Madrid: TEA Ediciones.
Schiemann, S. (2003). Entwicklung und Erprobung einer Testbatterie zur Diagnostik 
bei Simulationsverdacht [Development and evaluation of a test battery for the de-
tection of malingering]. Psychology Science, 45, 80-100. 
Schmand, B., de Sterke, S., & Lindeboom, J. (1999). Amsterdamse Korte Termijn Geheugen 
test [Amsterdam Short-Term Memory Test]. Lisse, NL: Swets & Zeitlinger.
Schmand, B., & Lindeboom, J. (2005). Amsterdam Short-Term Memory Test. Manual.
Leiden, The Netherlands: PITS.
Schmand, B., Lindeboom, J., Schagen, S., Heijt, R., Koene, T., & Hamburger, H. L. (1998). 
Cognitive complaints in patients after whiplash injury: The impact of malingering. 
Journal of Neurology, Neurosurgery, and Psychiatry, 64, 339-343.
Schmand, B., & Ponds, R. (1997). Malingeren: simuleren en aggraveren [Malingering: 
simulation and aggravation]. In: B. Deelman, P. Eling, E. de Haan, A. Jennekens-
Schinkel, E. van Zomeren (Eds.), Klinische Neuropsychology [Clinical Neuropsycholo-
gy] (pp. 426-436). Amsterdam: Boom.
Schmidt, T., Lanquillon, S., & Ullmann, U. (2011). Kontroverse zu Beschwerdenvali-
dierungsverfahren bei der Begutachtung psychischer Störung [Controversy of 
symptom validity assessment in forensic evaluation of mental disorders]. Forensis-
che Psychiatrie Psychologie Kriminologie, 5, 177-183.
Schmidt-Atzert, L., Bühner, M., Rischen, S., & Warkentin, V. (2004). Erkennen von Si-
mulation und Dissimulation im Test d2 [Detection of malingering and dissimula-
tion in d2 test]. Diagnostica, 50, 124-133.
Schroeder, R. W., Peck, C. P., Buddin, W. H., Heinrichs, R. J., & Baade, L. E. (2012). The 
Coin-in-the-Hand Test and dementia: More evidence for a screening test for neu-
rocognitive symptom exaggeration. Cognitive and Behavioral Neurology, 25, 139-143.
Simões, M., Sousa, L., Duarte, P., Firmino, H., Pinho, M. S., Gaspar, N., … França, S. 
(2010). Avaliação da simulação ou esforço insuficiente com o Rey 15-Item Memory 
Test (15-IMT): Estudos de validação em grupos de adultos idosos [Validation of si-
mulation or insufficient effort with the Rey 15-IMT: Validation studies in aged 
adult groups]. Análise Psicológica, 28, 209–226.
Singhal, A., Green, P., Ashaye, K., Shankar, K., & Gill, D. (2009). High specificity of the 
Medical Symptom Validity Test in patients with very severe memory impairment. 
Archives of Clinical Neuropsychology, 24, 721-728.
Slick, D. J., Sherman, E. M., & Iverson, G. L. (1999). Diagnostic criteria for malingered 
neurocognitive dysfunction: Proposed standards for clinical practice and re-
search. The Clinical Neuropsychologist, 13, 545-561.
Spreen, O. (1963). MMPI-Saarbrücken. Handbuch zur deutschen Ausgabe des MMPI von 
S. R. Hathaway und J. C. McKinley [MMPI Saarbrücken: Manual of the German edi-
tion of the MMPI by S. R. Hathaway and J. C. McKinley]. Bern: Huber.
Squires, N. (2013, August 01). Greece tries to crack down on fraud as mayor of Zakyn-
thos faces revolt. The Telegraph. Retrieved from http://www.telegraph.co.uk/news/
worldnews/europe/greece.
Stevens, A., Fabra, M., & Merten, T. (2009). Anleitung für die Erstellung psych iatrischer 
Gutachten [Directions for forensic psychiatric examinations]. Der medizinische Sa-
chverständige, 105, 100-106.
Stevens, A., Friedel, E., Mehren, G., & Merten, T. (2008). Malingering and uncooperati-
veness in psychiatric and psychological assessment: Pre va lence and effects in a 
German sample of claimants. Psychiatry Research, 157, 191-200.
Sweet, J. J., & Guidotti-Breting, L. M. (2013). Symptom validity test research: Status and 
clinical implications. Journal of Experimental Psychopathology, 4, 6-19.
Thomann, K. D., & Rauschmann, M. A. (2003). Von der „railway spine” zum Schleuder-
trauma: Geschichte und aktuelle Bedeutung seelischer Störungen nach entschädi-
gungspflichtigen Ereignissen [From “railway spine“ to whiplash injury]. Zeitschrift 
für die gesamte Versicherungswissenschaft, 92, 533-577.
Tombaugh, T. N. (1996). Test of Memory Malingering (TOMM). North Tonawanda, NY: 
Multi-Health Systems.
Vallabhajosula, B., & van Gorp, W. G. (2001). Post-Daubert admissibility of scientific 
evidence on malingering of cognitive deficits. Journal of the American Academy of 
Psychiatry Law, 29, 207–215.
Van der Werf, S. P., Prins, J. B., Jonge, P. J., van der Meer, J. W., & Bleijenberg, G. (2000). 
Abnormal neuropsychological findings are not necessarily a sign of cerebral im-
pairment: a matched comparison between chronic fatigue syndrome and multiple 
sclerosis. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 13, 199-203. 
Van Zomeren, E., & Saan, R. (1997). Whiplash. In B. Deelman, P. Eling, E. de Haan, A. 
Jennekens-Schinkel, & E. van Zomeren (Eds.), Klinische Neuropsychology [Clinical 
Neuropsychology] (pp. 290-298). Amsterdam: Boom. 
Vilar-López, R., & Aliaga, A. (2009). Evaluación de la simulación de problemas cogniti-
vos [Assessment of cognitive problems malingering]. In A. Jarne, T. Villaseñor, & A. 
Aliaga (Eds.), Manual de neuropsicología forense. Barcelona: Paidós.
Vilar-López, R., Gómez-Río, M., Caracuel-Romero, A., Llamas-Elvira, J., & Pérez-García, 
M. (2008). Use of specific malingering measures in a Spanish sample. Journal of 
Clinical and Experimental Neuropsychology, 30, 710-722. 
Vilar-López, R., Pérez-García, M., & Puente, A. (2011). Adaptación española del Test de 
Simulación de Problemas de Memoria TOMM [Spanish adaptation of the Test of Me-
mory Malingering]. Madrid: TEA Ediciones.
Warrington, E. K. (1984). Recognition Memory Test. Windsor, England: NFER-Nelson.
Widows, M. R., & Smith, G. P. (2005). SIMS-Structured Inventory of Malingered Sympto-
matology. Professional manual. Lutz, FL: Psychological Assessment Resources.
Wogar, M. A., van den Broek, M. V. D., Bradshaw, C. M., & Szabadi, E. (1998). A new 
performance-curve method for the detection of simulated cognitive impairment. 
British Journal of Clinical Psychology, 37, 327-339.
Zaldivar-Basurto, F., García-Montes, J. M., López-Rios, F., Molina-Moreno, A., & Santia-
go, E. (2007). Adaptación y validación al castellano de la Evaluación Forense de Miller 
del Test de Síntomas (M-FAST) [Spanish adaptation and validation of the Miller-Fo-
rensic Assessment of Symptoms Test]. Paper presented at the 3rd Congreso de Psi-
cología Jurídica y Forense. Oviedo: Ediciones de la Universidad de Oviedo.
